Clinical trial
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy…
NCT00439569 · Westat, Other · Terminated
Key facts
| NCT number | NCT00439569 |
|---|---|
| Title | Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III |
| Official title | Phase I/IIa Clinical Trial of Sodium Phenylbutyrate in Pediatric Subjects With Type II/III Spinal Muscular Atrophy |
| Acronym | NPTUNE01 |
| Lead sponsor | Westat, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Spinal Muscular Atrophy Type II, Spinal Muscular Atrophy Type III |
| Intervention type | Drug |
| Interventions | sodium phenylbutyrate |
| Enrollment | 9 |
| Start date | Jan 1, 2008 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Feb 23, 2007 |
| Last update posted | Sep 8, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: